{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:47:45Z","timestamp":1765374465353,"version":"3.46.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.toxrep.2025.102164","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T04:08:35Z","timestamp":1762834115000},"page":"102164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Modulation of PM20D1 expression by rosiglitazone confers neuroprotection in tramadol-induced Parkinsonian rats"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8022-3684","authenticated-orcid":false,"given":"Farah Hazim","family":"Hadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda Jaber","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawfal Abdulmonem","family":"Numan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.toxrep.2025.102164_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxrep.2025.102164_bib2","series-title":"Techniques for assessment of Parkinsonism for diagnosis and rehabilitation","first-page":"1","article-title":"Parkinson\u2019s disease\u2013an introduction","author":"Rawat","year":"2021"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson's disease and relevant therapeutic options: A review of the literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.toxrep.2025.102164_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"issue":"8","key":"10.1016\/j.toxrep.2025.102164_bib5","first-page":"1281","article-title":"The etiology of Parkinson\u2019s disease: new perspectives from gene-environment interactions","volume":"13","author":"Bogers","year":"2023","journal-title":"J. Park. \u2019S. Dis."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102164_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/1570159X14666160104142223","article-title":"Nutraceuticals against Neurodegeneration: A Mechanistic Insight","volume":"14","author":"Dadhania","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102164_bib7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.toxrep.2025.102164_bib8","article-title":"Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxid. (Basel)"},{"issue":"7","key":"10.1016\/j.toxrep.2025.102164_bib9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson\u2019s disease","volume":"16","author":"Dorszewska","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.expneurol.2009.04.002","article-title":"beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-)","volume":"217","author":"Liu","year":"2009","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib11","article-title":"The Potential Effects of Oxidative Stress-Related Plasma Abnormal Protein Aggregate Levels on Brain Volume and Its Neuropsychiatric Consequences in Parkinson\u2019s Disease","volume":"2021","author":"Chen","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11940-009-0019-3","article-title":"Drug-induced parkinsonism","volume":"11","author":"Susatia","year":"2009","journal-title":"Curr. Treat. Options Neurol."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1515\/jbcpp-2018-0113","article-title":"Tramadol-induced parkinsonism: a case report of a 75-year-old woman","volume":"30","author":"Singh","year":"2019","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.102164_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.parkreldis.2019.12.011","article-title":"Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database","volume":"70","author":"de Germay","year":"2020","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin","year":"2012","journal-title":"J. Clin. Neurol. (Seoul. Korea)"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0002784","article-title":"Prevalence and health consequences of nonmedical use of tramadol in Africa: A systematic scoping review","volume":"4","author":"Boun","year":"2024","journal-title":"PLOS Glob. Public Health"},{"issue":"10","key":"10.1016\/j.toxrep.2025.102164_bib17","first-page":"758","article-title":"Neurobehavioral consequences associated with long term tramadol utilization and pathological mechanisms","volume":"18","author":"Khadga","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib18","article-title":"Tramadol Toxicity and Its Implications for Brain Disorders: A Narrative Review","volume":"9","author":"Sadrinasab","year":"2023","journal-title":"J. Otorhinolaryngol. Facial Plast. Surg."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102164_bib19","first-page":"461","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Park. 's. Dis."},{"key":"10.1016\/j.toxrep.2025.102164_bib20","article-title":"Chronic exposure to tramadol and neurodegeneration: A literature review","volume":"37","author":"Hashemizadeh","year":"2025","journal-title":"Toxicol. Anal. Et. Clin."},{"key":"10.1016\/j.toxrep.2025.102164_bib21","article-title":"Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs","volume":"2017","author":"Thangavel","year":"2017","journal-title":"Int. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102164_bib22","first-page":"P25","article-title":"The intriguing thiazolidinediones as PPAR \u03b3 agonists: a review","volume":"13","author":"Madhuri","year":"2023","journal-title":"Int J. Life Sci. Pharma Res. 2023"},{"issue":"7","key":"10.1016\/j.toxrep.2025.102164_bib23","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/biology12071042","article-title":"Exploring rosiglitazone\u2019s potential to treat alzheimer\u2019s disease through the modulation of brain-derived neurotrophic factor","volume":"12","author":"Nelson","year":"2023","journal-title":"Biology"},{"issue":"8","key":"10.1016\/j.toxrep.2025.102164_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/0115734064295063240422100615","article-title":"PPARs (Peroxisome Proliferator-activated Receptors) and their agonists in alzheimer's disease","volume":"20","author":"Kumar","year":"2024","journal-title":"Med. Chem."},{"key":"10.1016\/j.toxrep.2025.102164_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100871","article-title":"PPAR\u03b4 and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson's disease","volume":"78","author":"Altinoz","year":"2021","journal-title":"Mol. Asp. Med."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102164_bib26","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.3390\/ijms24043201","article-title":"Development of PPAR\u03b3 agonists for the treatment of neuroinflammatory and neurodegenerative diseases: Leriglitazone as a promising candidate","volume":"24","author":"Pizcueta","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib27","article-title":"Neuroprotective effect and mechanism of thiazolidinedione on dopaminergic neurons in vivo and in vitro in Parkinson\u2019s disease","volume":"2017","author":"Wang","year":"2017","journal-title":"PPAR Res."},{"issue":"18","key":"10.1016\/j.toxrep.2025.102164_bib28","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.3390\/ijms221810161","article-title":"Elucidating the neuroprotective role of PPARs in Parkinson\u2019s disease: a neoteric and prospective target","volume":"22","author":"Behl","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.toxrep.2025.102164_bib29","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/mds.27128","article-title":"Glitazone use associated with reduced risk of Parkinson's disease","volume":"32","author":"Brakedal","year":"2017","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102164_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/1570159X19666211109141330","article-title":"Advances in PPARs molecular dynamics and glitazones as a repurposing therapeutic strategy through mitochondrial redox dynamics against neurodegeneration","volume":"20","author":"Durai","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102164_bib31","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3390\/ijms24043264","article-title":"PPARs and their neuroprotective effects in parkinson\u2019s disease: a novel therapeutic approach in \u03b1-synucleinopathy?","volume":"24","author":"P\u00e9rez-Segura","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib32","first-page":"477","article-title":"Monoamine Oxidase-B inhibitors for the treatment of parkinson's disease: past, present, and future","volume":"12","author":"Tan","year":"2022","journal-title":"J. Park. 's. Dis."},{"key":"10.1016\/j.toxrep.2025.102164_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.12688\/f1000research.10100.1","article-title":"Recent advances in treating Parkinson's disease","volume":"6","author":"Oertel","year":"2017","journal-title":"F1000Research"},{"issue":"4","key":"10.1016\/j.toxrep.2025.102164_bib34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/biom11040612","article-title":"Treatment options for motor and non-motor symptoms of Parkinson\u2019s disease","volume":"11","author":"Church","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.toxrep.2025.102164_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.805388","article-title":"Molecular mechanisms and therapeutic strategies for levodopa-induced dyskinesia in Parkinson\u2019s disease: a perspective through preclinical and clinical evidence","volume":"13","author":"Bandopadhyay","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102164_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-025-01649-z","article-title":"Tirzepatide: a novel therapeutic approach for Alzheimer\u2019s disease","volume":"40","author":"Alshehri","year":"2025","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13148-020-0814-y","article-title":"Comprehensive analysis of PM20D1 QTL in Alzheimer\u2019s disease","volume":"12","author":"Sanchez-Mut","year":"2020","journal-title":"Clin. Epigenetics"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.20517\/jtgg.2022.10","article-title":"The many roles of the Alzheimer-associated gene PM20D1","volume":"6","author":"Garro-N\u00fa\u00f1ez","year":"2022","journal-title":"J. Transl. Genet. Genom."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib39","first-page":"361","article-title":"The many roles of the Alzheimer-associated gene PM20D1","volume":"6","author":"Diana","year":"2022","journal-title":"J. Transl. Genet. Genom."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.20517\/jtgg.2022.10","article-title":"The many roles of the Alzheimer-associated gene PM20D1","volume":"6","author":"Garro-N\u00fa\u00f1ez","year":"2022","journal-title":"J. Transl. Genet. Genom."},{"key":"10.1016\/j.toxrep.2025.102164_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177979","article-title":"A novel therapeutic prospect: a dual-acting tirzepatide for Alzheimer's disease","volume":"1003","author":"Alshehri","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41531-023-00578-x","article-title":"Alpha synuclein modulates mitochondrial Ca(2+) uptake from ER during cell stimulation and under stress conditions","volume":"9","author":"Ramezani","year":"2023","journal-title":"NPJ Park. 's. Dis."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1570159X16666180828100002","article-title":"Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update","volume":"17","author":"Khan","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib44","first-page":"1","article-title":"Tramadol Induces Neuroinflammation, Mitochondrial Oxidative Stress, Neurotransmitters Dysbalanced and Produced Parkinson\u2019s Disease Like Symptoms in Experimental Wistar Rats","volume":"38","author":"Aran","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxrep.2025.102164_bib45","unstructured":"Underwood W., Anthony R. AVMA guidelines for the euthanasia of animals: 2020 edition. Retrieved on March. 2020;2013(30):2020-1."},{"issue":"9","key":"10.1016\/j.toxrep.2025.102164_bib46","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1177\/0271678X20943823","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"40","author":"Percie du Sert","year":"2020","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib47","article-title":"Protective Effect of Opuntia dillenii (Ker Gawl.) Haw. Seed Oil on Gentamicin-Induced Nephrotoxicity: A Biochemical and Histological Analysis","volume":"2021","author":"Bouhrim","year":"2021","journal-title":"Sci. World J."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102164_bib48","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1080\/01480545.2021.1907909","article-title":"l-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease","volume":"45","author":"Raj","year":"2022","journal-title":"Drug Chem. Toxicol."},{"issue":"9","key":"10.1016\/j.toxrep.2025.102164_bib49","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1021\/acschemneuro.1c00022","article-title":"Neuroprotective efficacy of co-encapsulated rosiglitazone and vorinostat nanoparticle on streptozotocin induced mice model of Alzheimer disease","volume":"12","author":"KC","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/jnc.12190","article-title":"Neuroprotective effects of PPAR-\u03b3 agonist rosiglitazone in N171-82Q mouse model of Huntington's disease","volume":"125","author":"Jin","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxrep.2025.102164_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.110918","article-title":"Rosiglitazone regulates astrocyte polarization and neuroinflammation in a PPAR-\u03b3 dependent manner after experimental traumatic brain injury","volume":"209","author":"Ren","year":"2024","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib52","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00210-024-03359-2","article-title":"Effects of topical isoxsuprine ointment on imiquimod-induced psoriasiform skin inflammation in mice","volume":"398","author":"Khafaji","year":"2025","journal-title":"NaunynSchmiede 's. Arch. Pharmacol."},{"key":"10.1016\/j.toxrep.2025.102164_bib53","first-page":"1","article-title":"Evaluation of empagliflozin efficacy as a promising anti-aging treatment in mice: In-vivo study","volume":"71","author":"Obaid","year":"2024","journal-title":"Pharmacia"},{"issue":"7","key":"10.1016\/j.toxrep.2025.102164_bib54","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4103\/1673-5374.211194","article-title":"Neuroprotective potential of Quercetin in combination with piperine against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity","volume":"12","author":"Singh","year":"2017","journal-title":"Neural Regen. Res."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12640-015-9535-y","article-title":"Protective effect of spermidine against excitotoxic neuronal death induced by quinolinic acid in rats: possible neurotransmitters and neuroinflammatory mechanism","volume":"28","author":"Jamwal","year":"2015","journal-title":"Neurotox. Res."},{"issue":"43","key":"10.1016\/j.toxrep.2025.102164_bib56","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.toxrep.2025.102164_bib58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2009.09.103","article-title":"Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson's disease","volume":"1306","author":"Kim","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.toxrep.2025.102164_bib59","article-title":"Novel therapeutic effects of rifaximin in combination with methylprednisolone for LPS-induced \u200eoxidative stress and inflammation in mice\u200e: \u200eAn in vivo study","volume":"13","author":"Al-Naimi","year":"2024","journal-title":"Toxicol. Rep."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1385\/MO:22:2:177","article-title":"Apoptosis of lymphocytes in peripheral blood of patients with melanoma","volume":"22","author":"Tas","year":"2005","journal-title":"Med. Oncol. (North. Lond. Engl. )"},{"issue":"11","key":"10.1016\/j.toxrep.2025.102164_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30112394","article-title":"Bioassay-Guided Isolation and Active Compounds Identification of the AntiDiabetic Fractions of Centaurea calcitrapa Extract and the Predicted Interaction Mechanism","volume":"30","author":"Kadhim","year":"2025","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib62","doi-asserted-by":"crossref","first-page":"190","DOI":"10.31351\/vol33iss2pp190-196","article-title":"The Hepatoprotective Effect of Glycyrrhiza glabra Roots Extract Against Amiodarone Induced Hepatotoxicity in Male Rats","volume":"33","author":"Fadhil","year":"2024","journal-title":"Iraqi J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib63","first-page":"15","article-title":"A new photometric method for serum urea nitrogen determination","volume":"33","author":"Searcy","year":"1967","journal-title":"Am. J. Med. Technol."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib64","first-page":"83","article-title":"Creatinine determination according to Jaffe\u2014what does it stand for?","volume":"4","author":"Delanghe","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102164_bib65","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/clinchem\/hvab052","article-title":"Efficiency correction is required for accurate quantitative PCR analysis and reporting","volume":"67","author":"Ruijter","year":"2021","journal-title":"Clin. Chem."},{"issue":"12","key":"10.1016\/j.toxrep.2025.102164_bib66","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3390\/genes13122387","article-title":"Real-time polymerase chain reaction: current techniques, applications, and role in COVID-19 diagnosis","volume":"13","author":"Artika","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.toxrep.2025.102164_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.116688","article-title":"Carbamazepine induces hepatotoxicity in zebrafish by inhibition of the Wnt\/\u03b2-catenin signaling pathway","volume":"276","author":"Bai","year":"2021","journal-title":"Environ. Pollut."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/bcpt.14018","article-title":"The mitigating effect of para-hydroxycinnamic acid in bleomycin-induced pulmonary fibrosis in mice through targeting oxidative, inflammatory and fibrotic pathways","volume":"135","author":"Hussein","year":"2024","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102164_bib69","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.toxrep.2025.102164_bib70","first-page":"1","article-title":"Effects of a crude extract of Echinops mosulensis on an induced Parkinson\u2019s disease model in mice","volume":"71","author":"Ahmed","year":"2024","journal-title":"PHARMACIA"},{"key":"10.1016\/j.toxrep.2025.102164_bib71","unstructured":"Suvarna K.S., Layton C., Bancroft J.D. Bancroft's theory and practice of histological techniques E-Book. Elsevier health sciences; 2018."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13030653","article-title":"Isofraxidin Attenuates Lipopolysaccharide-Induced Cytokine Release in Mice Lung and Liver Tissues via Inhibiting Inflammation and Oxidative Stress","volume":"13","author":"Al-Naimi","year":"2025","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018025666","article-title":"Modulatory effects of melatonin against rotenone induced rat model of Parkinson's disease","volume":"37","author":"Rasheed","year":"2018","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102164_bib74","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3390\/ijms24043264","article-title":"PPARs and their neuroprotective effects in Parkinson\u2019s disease: a novel therapeutic approach in \u03b1-synucleinopathy?","volume":"24","author":"P\u00e9rez-Segura","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxrep.2025.102164_bib75","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.theriogenology.2024.06.006","article-title":"PPAR beta\/delta regulates the immune response mechanisms in the porcine endometrium during LPS-induced inflammation\u2013An in vitro study","volume":"226","author":"Golubska","year":"2024","journal-title":"Theriogenology"},{"issue":"5","key":"10.1016\/j.toxrep.2025.102164_bib76","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s11064-020-02993-5","article-title":"The novel role of PPAR alpha in the brain: promising target in therapy of Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"45","author":"W\u00f3jtowicz","year":"2020","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.toxrep.2025.102164_bib77","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.toxrep.2025.102164_bib78","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1007\/s11064-021-03402-1","article-title":"Peroxisome proliferator-activated receptor-gamma (PPAR-\u0263): molecular effects and its importance as a novel therapeutic target for cerebral ischemic injury","volume":"46","author":"Mannan","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.toxrep.2025.102164_bib79","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12640-019-00132-9","article-title":"Rational design, synthesis, and in vitro neuroprotective evaluation of novel glitazones for PGC-1\u03b1 activation via PPAR-\u03b3: a new therapeutic strategy for neurodegenerative disorders","volume":"37","author":"Justin","year":"2020","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib80","article-title":"Signaling mechanisms of selective PPAR\u03b3 modulators in Alzheimer\u2019s disease","volume":"2018","author":"Govindarajulu","year":"2018","journal-title":"PPAR Res."},{"key":"10.1016\/j.toxrep.2025.102164_bib81","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuroscience.2011.07.046","article-title":"Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model","volume":"194","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxrep.2025.102164_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-8-91","article-title":"The PPAR-\u03b3 agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys","volume":"8","author":"Swanson","year":"2011","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib83","first-page":"139","article-title":"Tramadol Induces Histological Aberrations, Downregulation of Bcl-2 and Upregulations of GFAP, P53 Immunoexpression in the Cerebellum of the Male Albino Rat","volume":"15","author":"Ali","year":"2023","journal-title":"Egypt. Acad. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib84","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/brain\/awaa401","article-title":"Targeted sequencing of Parkinson\u2019s disease loci genes highlights SYT11, FGF20 and other associations","volume":"144","author":"Rudakou","year":"2021","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.toxrep.2025.102164_bib85","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Sim\u00f3n-S\u00e1nchez","year":"2009","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.toxrep.2025.102164_bib86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/gm566","article-title":"Genetics and genomics of Parkinson's disease","volume":"6","author":"Lin","year":"2014","journal-title":"Genome Med."},{"issue":"11","key":"10.1016\/j.toxrep.2025.102164_bib87","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41418-024-01356-9","article-title":"The PM20D1-NADA pathway protects against Parkinson\u2019s disease","volume":"31","author":"Yang","year":"2024","journal-title":"Cell death Differ."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib88","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/acn3.38","article-title":"The regulation of catalase activity by PPAR \u03b3 is affected by \u03b1-synuclein","volume":"1","author":"Yakunin","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.toxrep.2025.102164_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-9-63","article-title":"The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function","volume":"9","author":"Gray","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib90","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/antiox11010142","article-title":"Influence of N-arachidonoyl dopamine and N-docosahexaenoyl dopamine on the expression of neurotrophic factors in neuronal differentiated cultures of human induced pluripotent Stem cells under conditions of oxidative stress","volume":"11","author":"Novosadova","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.toxrep.2025.102164_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102874","article-title":"Adverse bioenergetic effects of N-acyl amino acids in human adipocytes overshadow beneficial mitochondrial uncoupling","volume":"66","author":"Herrnhold","year":"2023","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib92","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1007\/s12013-024-01343-4","article-title":"Theoretical and Experimental Study of the Interaction of Protonophore Uncouplers and Decoupling Agents with Functionally Active Mitochondria","volume":"82","author":"Samartsev","year":"2024","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.toxrep.2025.102164_bib93","series-title":"Evolution of Bioenergetics from Elements to Life: Emergence of High Energy Mitochondria","first-page":"157","article-title":"Process of Oxidative Phosphorylation and Free Radical Generation","author":"Stowe","year":"2025"},{"issue":"2","key":"10.1016\/j.toxrep.2025.102164_bib94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018025666","article-title":"Melatonin Improves Behavioral and Biochemical Outcomes in a Rotenone-Induced Rat Model of Parkinson's Disease","volume":"37","author":"Rasheed","year":"2018","journal-title":"J. Environ. Pathol. Toxicol. Oncol. Off. Organ Int. Soc. Environ. Toxicol. Cancer"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib95","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.toxlet.2012.07.016","article-title":"Rosiglitazone, a PPAR-\u03b3 agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats","volume":"213","author":"Lee","year":"2012","journal-title":"Toxicol. Lett."},{"issue":"5","key":"10.1016\/j.toxrep.2025.102164_bib96","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1460-9568.2009.06657.x","article-title":"PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson\u2019s disease","volume":"29","author":"Schintu","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.toxrep.2025.102164_bib97","doi-asserted-by":"crossref","first-page":"35430","DOI":"10.32598\/ijmtfm.v12i1.35430","article-title":"Tramadol-induced organ toxicity via oxidative stress: a review study","volume":"12","author":"Mohammadnejad","year":"2022","journal-title":"Int J. Med Toxicol. Forensic Med"},{"issue":"3","key":"10.1016\/j.toxrep.2025.102164_bib98","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jnc.13152","article-title":"\u03b3 induces neurotrophic factor-\u03b11 transcription contributing to neuroprotection","volume":"134","author":"Thouennon","year":"2015","journal-title":"J. Neurochem."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025002835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025002835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:47:51Z","timestamp":1765370871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750025002835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":98,"alternative-id":["S2214750025002835"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102164","relation":{},"ISSN":["2214-7500"],"issn-type":[{"type":"print","value":"2214-7500"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of PM20D1 expression by rosiglitazone confers neuroprotection in tramadol-induced Parkinsonian rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102164"}}